TrialArthritis research & therapy2019

Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis.

Dafna D Gladman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.